Erratum: Equivalence of glatiramer acetate generics with branded glatiramer acetate in efficacy and cost for the treatment of multiple sclerosis (JAMA Neurol. (2015) 1-3 10.1001/jamaneurol.2015.2605)

Dennis Bourdette, D. Hartung

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)1537
Number of pages1
JournalJAMA Neurology
Volume72
Issue number12
DOIs
StatePublished - Dec 1 2015

Fingerprint

Health Care Costs
Multiple Sclerosis
Glatiramer Acetate

ASJC Scopus subject areas

  • Clinical Neurology

Cite this

@article{78ebffe322394fa7b223b7ba7be08bf3,
title = "Erratum: Equivalence of glatiramer acetate generics with branded glatiramer acetate in efficacy and cost for the treatment of multiple sclerosis (JAMA Neurol. (2015) 1-3 10.1001/jamaneurol.2015.2605)",
author = "Dennis Bourdette and D. Hartung",
year = "2015",
month = "12",
day = "1",
doi = "10.1001/jamaneurol.2015.4174",
language = "English (US)",
volume = "72",
pages = "1537",
journal = "JAMA Neurology",
issn = "2168-6149",
publisher = "American Medical Association",
number = "12",

}

TY - JOUR

T1 - Erratum

T2 - Equivalence of glatiramer acetate generics with branded glatiramer acetate in efficacy and cost for the treatment of multiple sclerosis (JAMA Neurol. (2015) 1-3 10.1001/jamaneurol.2015.2605)

AU - Bourdette, Dennis

AU - Hartung, D.

PY - 2015/12/1

Y1 - 2015/12/1

UR - http://www.scopus.com/inward/record.url?scp=84950278348&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84950278348&partnerID=8YFLogxK

U2 - 10.1001/jamaneurol.2015.4174

DO - 10.1001/jamaneurol.2015.4174

M3 - Article

AN - SCOPUS:84950278348

VL - 72

SP - 1537

JO - JAMA Neurology

JF - JAMA Neurology

SN - 2168-6149

IS - 12

ER -